Jill Beraud's Insider Trades & SAST Disclosures
Jill Beraud's most recent trade in Levi Strauss & Co. - Ordinary Shares Cls A was a trade of 104 Class B Common Stock done . Disclosure was reported to the exchange on May 9, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jill Beraud.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 104 | 13,998 | - | - | Class B Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 88 | 172,534 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | 23 Apr 2025 | 108,679 | 160,756 (0%) | 0% | 0 | Class A Common Stock | ||
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | 23 Apr 2025 | 108,679 | 13,894 | - | - | Class B Common Stock | ||
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 11,690 | 172,446 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 99 | 122,573 | - | - | Class B Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 56 | 52,077 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 106 | 122,474 | - | - | Class B Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 60 | 52,021 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 93 | 122,368 | - | - | Class B Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 52 | 51,961 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 74 | 122,275 | - | - | Class B Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 42 | 51,909 (0%) | 0% | 0 | Class A Common Stock | |
| Revance Therapeutics Inc | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 23,458 | 23,458 | - | - | Stock Option (Right to buy) | |
| Revance Therapeutics Inc | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 15,000 | 43,606 (0%) | 0% | 0 | Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 7,642 | 51,867 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 88 | 122,201 | - | - | Class B Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 69 | 44,225 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 112 | 122,113 | - | - | Class B Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 87 | 44,156 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 113 | 122,001 | - | - | Class B Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 88 | 44,069 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 129 | 43,981 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 117 | 121,888 | - | - | Class B Common Stock | |
| Revance Therapeutics Inc | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 5,915 | 5,915 | - | - | Stock Option (Right to buy) | |
| Revance Therapeutics Inc | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 3,534 | 28,606 (0%) | 0% | 0 | Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2023 | 10,251 | 43,852 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 87 | 77,707 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 81 | 77,962 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2022 | 190 | 77,794 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 152 | 77,604 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 222 | 77,452 (0%) | 0% | 0 | Class A Common Stock | |
| Revance Therapeutics Inc | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 10,756 | 10,756 | - | - | Stock Option (Right to buy) | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2022 | 7,812 | 77,230 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 129 | 69,418 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 81 | 69,289 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2021 | 94 | 69,208 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 5,455 | 69,114 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 72 | 63,659 (0%) | 0% | 0 | Class A Common Stock | |
| Revance Therapeutics Inc | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 7,551 | 7,551 | - | - | Stock Option (Right to buy) | |
| Revance Therapeutics Inc | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 4,013 | 19,013 (0%) | 0% | 0 | Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 56 | 63,587 (0%) | 0% | 0 | Class A Common Stock | |
| Levi Strauss & Co. - Ordin... | Jill Beraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 12,449 | 63,531 (0%) | 0% | 0 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges